How is REM sleep behavior disorder linked to neurodegenerative disease?

How is REM sleep behavior disorder linked to neurodegenerative disease?

• A. It is caused by antidepressants
• B. It is a benign condition
• C. It resolves with melatonin
• D. It can precede synucleinopathies such as Parkinson's disease

Answer: (D)

REM sleep behavior disorder shows a loss of the normal REM-atonia that keeps muscles relaxed during dreaming, due to degeneration in brainstem circuits that control this atonia. This disruption is meaningful because in many people it isn’t just a stand-alone issue—the disorder often serves as an early sign of a neurodegenerative process known as a synucleinopathy. Over time, many individuals with idiopathic REM sleep behavior disorder go on to develop conditions such as Parkinson’s disease, dementia with Lewy bodies, or multiple system atrophy, sometimes years after the RBD first appears. The underlying biology supports this link: abnormal alpha-synuclein pathology starts in brainstem regions involved in REM atonia and can spread to other brain areas affected by these diseases, aligning the sleep disorder with later neurodegenerative changes. So, the best-held connection is that REM sleep behavior disorder can precede synucleinopathies like Parkinson’s disease. Antidepressants can trigger RBD in some cases, and while melatonin or other treatments may ease symptoms, they don’t establish this disorder as benign or prevent its progression to a neurodegenerative disease.

REM sleep behavior disorder shows a loss of the normal REM-atonia that keeps muscles relaxed during dreaming, due to degeneration in brainstem circuits that control this atonia. This disruption is meaningful because in many people it isn’t just a stand-alone issue—the disorder often serves as an early sign of a neurodegenerative process known as a synucleinopathy. Over time, many individuals with idiopathic REM sleep behavior disorder go on to develop conditions such as Parkinson’s disease, dementia with Lewy bodies, or multiple system atrophy, sometimes years after the RBD first appears. The underlying biology supports this link: abnormal alpha-synuclein pathology starts in brainstem regions involved in REM atonia and can spread to other brain areas affected by these diseases, aligning the sleep disorder with later neurodegenerative changes.

So, the best-held connection is that REM sleep behavior disorder can precede synucleinopathies like Parkinson’s disease. Antidepressants can trigger RBD in some cases, and while melatonin or other treatments may ease symptoms, they don’t establish this disorder as benign or prevent its progression to a neurodegenerative disease.